{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:06:14Z","timestamp":1793307974204,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.acra.2026.06.015","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T19:44:41Z","timestamp":1783194281000},"page":"3959-3972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Advances in CT and MRI for Yttrium-90 Radioembolization of Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"33","author":[{"given":"Hong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Pieterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy S.","family":"Dwarkasing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acra.2026.06.015_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.acra.2026.06.015_bib2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.acra.2026.06.015_bib3","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.acra.2026.06.015_bib4","doi-asserted-by":"crossref","first-page":"974","DOI":"10.21037\/hbsn-23-504","article-title":"Selective internal radiation therapy across Barcelona Clinic Liver Cancer (BCLC) stages of hepatocellular carcinoma: literature review","volume":"13","author":"Vigneron","year":"2024","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.acra.2026.06.015_bib5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1055\/s-0044-1788006","article-title":"Cone beam computed tomography for the interventional oncologist: a practical approach","volume":"41","author":"May","year":"2024","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.acra.2026.06.015_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.diii.2020.09.003","article-title":"Comparison of perfused volume segmentation between cone-beam CT and 99mTc-MAA SPECT\/CT for treatment dosimetry before selective internal radiation therapy using 90Y-glass microspheres","volume":"102","author":"Martin","year":"2021","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.acra.2026.06.015_bib7","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1148\/radiol.211806","article-title":"Defreyne, 90Y radioembolization versus drug-eluting bead chemoembolization for unresectable hepatocellular carcinoma: results from the TRACE phase II randomized controlled Trial","volume":"303","author":"Dhondt","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2026.06.015_bib8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/j.semnuclmed.2019.01.003","article-title":"The role of radioembolization in bridging and downstaging hepatocellular carcinoma to curative therapy","volume":"49","author":"Titano","year":"2019","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.acra.2026.06.015_bib9","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.3390\/tomography8060224","article-title":"Prediction of lung shunt fraction for Yttrium-90 treatment of hepatic tumors using dynamic contrast enhanced MRI with quantitative perfusion processing","volume":"8","author":"Zhang","year":"2022","journal-title":"Tomography"},{"key":"10.1016\/j.acra.2026.06.015_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2147\/JHC.S391537","article-title":"Non-invasive imaging biomarkers to predict the hepatopulmonary shunt fraction before transarterial radioembolization in patients with hepatocellular carcinoma","volume":"10","author":"Hamm","year":"2023","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.acra.2026.06.015_bib11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jvir.2024.10.007","article-title":"Streamlining radioembolization without lung shunt estimation versus regular radioembolization in patients with hepatocellular carcinoma within the milan criteria","volume":"36","author":"Kim","year":"2025","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.acra.2026.06.015_bib12","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1007\/s00330-023-09390-w","article-title":"Accuracy and reproducibility of a cone beam CT-based virtual parenchymal perfusion algorithm in the prediction of SPECT\/CT anatomical and volumetric results during the planification of radioembolization for HCC","volume":"33","author":"Derbel","year":"2023","journal-title":"Eur Radiol"},{"key":"10.1016\/j.acra.2026.06.015_bib13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00270-019-02198-6","article-title":"Feasibility of Yttrium-90 radioembolization dose calculation utilizing intra-procedural open trajectory cone beam CT","volume":"43","author":"O'Connor","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.acra.2026.06.015_bib14","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11547-024-01946-0","article-title":"Radioembolization for hepatocellular carcinoma: a comparison on dual-phase cone-beam CT, contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT\/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET\/CT","volume":"130","author":"di Gaeta","year":"2025","journal-title":"Radiol Med"},{"key":"10.1016\/j.acra.2026.06.015_bib15","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1002\/mp.16882","article-title":"Intraprocedural C-arm dual-phase cone-beam enhancement patterns correlate with tumor absorbed dose after radioembolization","volume":"51","author":"Bastiaannet","year":"2024","journal-title":"Med Phys"},{"key":"10.1016\/j.acra.2026.06.015_bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/bjr\/tqad056","article-title":"Quantitative differences in volumetric calculations for radiation dosimetry in segmental Y90 treatment planning using hybrid angiography-CT compared with anatomic segmentation","volume":"97","author":"Kwak","year":"2024","journal-title":"Br J Radiol"},{"key":"10.1016\/j.acra.2026.06.015_bib17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jvir.2020.10.021","article-title":"Radiation dose during transarterial radioembolization: a dosimetric comparison of cone-beam CT and angio-CT technologies","volume":"32","author":"Marshall","year":"2021","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.acra.2026.06.015_bib18","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.3390\/jcm10173837","article-title":"Comparison of the uptake of hepatocellular carcinoma on pre-therapeutic MDCT, CACT, and SPECT\/CT, and the correlation with post-therapeutic PET\/CT in patients undergoing selective internal radiation therapy","volume":"10","author":"Meine","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.acra.2026.06.015_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2024.103384","article-title":"A microscopic model of the dose distribution in hepatocellular carcinoma after selective internal radiation therapy","volume":"122","author":"Cutr\u00ec","year":"2024","journal-title":"Phys Med"},{"key":"10.1016\/j.acra.2026.06.015_bib20","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2967\/jnumed.124.267421","article-title":"PET\/CT-based absorbed dose maps in 90Y selective internal radiation therapy correlate with spatial changes in liver function derived from dynamic MRI","volume":"65","author":"Lu","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.acra.2026.06.015_bib21","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1007\/s00261-020-02855-2","article-title":"Analysis of dynamic hepatobiliary contrast-enhanced MRI signal intensity after Yttrium-90 radioembolization with glass microspheres for the treatment of hepatocellular carcinoma","volume":"46","author":"Syed","year":"2021","journal-title":"Abdom Radiol ((NY))"},{"key":"10.1016\/j.acra.2026.06.015_bib22","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.hpb.2022.08.003","article-title":"Radiological and pathological assessment with EOB-MRI after Y90 radiation lobectomy prior to liver resection for hepatocellular carcinoma","volume":"24","author":"Bekki","year":"2022","journal-title":"HPB ((Oxford))"},{"key":"10.1016\/j.acra.2026.06.015_bib23","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/cancers16030586","article-title":"Anatomical quantitative volumetric evaluation of liver segments in hepatocellular carcinoma patients treated with selective internal radiation therapy: key parameters influencing untreated liver hypertrophy","volume":"16","author":"Girardet","year":"2024","journal-title":"Cancers ((Basel))"},{"key":"10.1016\/j.acra.2026.06.015_bib24","doi-asserted-by":"crossref","first-page":"7427","DOI":"10.1002\/mp.15270","article-title":"A deep-learning-based prediction model for the biodistribution of 90Y microspheres in liver radioembolization","volume":"48","author":"Plachouris","year":"2021","journal-title":"Med Phys"},{"key":"10.1016\/j.acra.2026.06.015_bib25","doi-asserted-by":"crossref","first-page":"20718","DOI":"10.1038\/s41598-022-25077-6","article-title":"Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validation","volume":"12","author":"Theysohn","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.acra.2026.06.015_bib26","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.ijrobp.2023.01.055","article-title":"Predictive model of liver toxicity to aid the personalized selection of proton versus photon therapy in hepatocellular carcinoma","volume":"116","author":"Chamseddine","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.acra.2026.06.015_bib27","doi-asserted-by":"crossref","first-page":"22288","DOI":"10.1038\/s41598-023-49787-7","article-title":"CT texture features and lung shunt fraction measured using 99mTc-macroaggregated albumin SPECT\/CT before trans-arterial radioembolization for hepatocellular carcinoma patients","volume":"13","author":"Lee","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.acra.2026.06.015_bib28","doi-asserted-by":"crossref","first-page":"765","DOI":"10.5009\/gnl19197","article-title":"The modified response evaluation criteria in solid tumors (RECIST) yield a more accurate prognoses than the RECIST 1.1 in hepatocellular carcinoma treated with transarterial radioembolization","volume":"14","author":"Lee","year":"2020","journal-title":"Gut Liver"},{"key":"10.1016\/j.acra.2026.06.015_bib29","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jhep.2019.09.026","article-title":"mRECIST for HCC: performance and novel refinements","volume":"72","author":"Llovet","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.acra.2026.06.015_bib30","unstructured":"American College of Radiology, LI-RADS CT\/MRI radiation TRA v2024 core. \u3008https:\/\/www.acr.org\/-\/media\/ACR\/Files\/RADS\/LI-RADS\/LI-RADS-CTMR-Radiation-TRA-v2024-Core\u3009, 2024 (accessed 27.07.2024)."},{"key":"10.1016\/j.acra.2026.06.015_bib31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1148\/radiol.2015142951","article-title":"Comparison of existing response criteria in patients with hepatocellular carcinoma treated with transarterial chemoembolization using a 3D quantitative approach","volume":"278","author":"Tacher","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2026.06.015_bib32","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3348\/kjr.2020.1159","article-title":"LI-RADS version 2018 treatment response algorithm: diagnostic performance after transarterial radioembolization for hepatocellular carcinoma","volume":"22","author":"Yoon","year":"2021","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.acra.2026.06.015_bib33","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1007\/s00330-024-11253-x","article-title":"Prognostic value of early response in predicting survival in hepatocellular carcinoma patients treated with selective internal radiation therapy","volume":"35","author":"Dupuis","year":"2025","journal-title":"Eur Radiol"},{"key":"10.1016\/j.acra.2026.06.015_bib34","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1007\/s11604-025-01785-7","article-title":"Application of LI-RADS CT\/MRI radiation treatment response assessment version 2024: a study after transarterial radioembolization for hepatocellular carcinoma","volume":"43","author":"Shin","year":"2025","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.acra.2026.06.015_bib35","doi-asserted-by":"crossref","first-page":"7349","DOI":"10.1007\/s00330-025-11659-1","article-title":"Temporal evolution of the LI-RADS radiation treatment response assessment on multiphase CT\/MRI in patients undergoing selective internal radiation therapy for hepatocellular carcinoma","volume":"35","author":"Wei","year":"2025","journal-title":"Eur Radiol"},{"key":"10.1016\/j.acra.2026.06.015_bib36","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.25.32745","article-title":"LI-RADS CT\/MRI radiation treatment response assessment version 2024: category redistribution and short-term outcomes in patients undergoing 90Y radioembolization for HCC","volume":"225","author":"Chiu","year":"2025","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.acra.2026.06.015_bib37","doi-asserted-by":"crossref","first-page":"7549","DOI":"10.1007\/s00330-025-11730-x","article-title":"Evaluation of the LI-RADS radiation treatment response assessment v2024 in comparison with the modified RECIST","volume":"35","author":"Kim","year":"2025","journal-title":"Eur Radiol"},{"key":"10.1016\/j.acra.2026.06.015_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.diii.2020.09.004","article-title":"Prediction of overall survival in patients with hepatocellular carcinoma treated with Y-90 radioembolization by imaging response criteria","volume":"102","author":"Ghosn","year":"2021","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.acra.2026.06.015_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.109351","article-title":"Response assessment of hepatocellular carcinoma treated with yttrium-90 radioembolization: inter-reader variability, comparison with 3D quantitative approach, and role in the prediction of clinical outcomes","volume":"133","author":"King","year":"2020","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.acra.2026.06.015_bib40","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.1007\/s00330-022-08732-4","article-title":"Assessment of HCC response to Yttrium-90 radioembolization with gadoxetate disodium MRI: correlation with histopathology","volume":"32","author":"Vietti Violi","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.acra.2026.06.015_bib41","first-page":"6828","article-title":"Computed tomographic perfusion imaging for the prediction of response transarterial radioembolization with Yttrium-90 glass microspheres of hepatocellular carcinoma","volume":"25","author":"Kaplan","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.acra.2026.06.015_bib42","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1007\/s00330-020-07636-5","article-title":"Early effect of 90Y radioembolisation on hepatocellular carcinoma and liver parenchyma stiffness measured with MR elastography: initial experience","volume":"31","author":"Kennedy","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.acra.2026.06.015_bib43","doi-asserted-by":"crossref","DOI":"10.1148\/rycan.2020190094","article-title":"Assessment of hepatocellular carcinoma response to 90Y radioembolization using dynamic contrast material-enhanced MRI and intravoxel incoherent motion diffusion-weighted imaging","volume":"2","author":"Hectors","year":"2020","journal-title":"Radiol Imaging Cancer"},{"key":"10.1016\/j.acra.2026.06.015_bib44","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.21873\/anticanres.14419","article-title":"Radioembolization-induced tumor calcifications as a surrogate marker of tumor response in patients with hepatocellular carcinoma","volume":"40","author":"Kim","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.acra.2026.06.015_bib45","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210294","article-title":"Tumour-to-normal tissue (T\/N) dosimetry ratios role in assessment of 90Y selective internal radiation therapy (SIRT)","volume":"95","author":"Kne\u0161aurek","year":"2022","journal-title":"Br J Radiol"},{"key":"10.1016\/j.acra.2026.06.015_bib46","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3390\/biology10080728","article-title":"Sarcopenia worsening one month after transarterial radioembolization predicts progressive disease in patients with advanced hepatocellular carcinoma","volume":"10","author":"Vallati","year":"2021","journal-title":"Biology ((Basel))"},{"key":"10.1016\/j.acra.2026.06.015_bib47","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jvir.2022.11.004","article-title":"Prediction of response of hepatocellular carcinoma to radioembolization: machine learning using preprocedural clinical factors and MR imaging radiomics","volume":"34","author":"\u0130nce","year":"2023","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.acra.2026.06.015_bib48","article-title":"Predicting treatment responses using magnetic resonance imaging-based radiomics in hepatocellular carcinoma patients undergoing transarterial radioembolization","volume":"70","author":"Sozutok","year":"2024","journal-title":"Rev Assoc Med Bras ((1992))"},{"key":"10.1016\/j.acra.2026.06.015_bib49","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222891","article-title":"Using machine learning to predict response to image-guided therapies for hepatocellular carcinoma","volume":"309","author":"Hsieh","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2026.06.015_bib50","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11307-025-01992-8","article-title":"Potential of radiomics, dosiomics, and dose volume histograms for tumor response prediction in hepatocellular carcinoma following 90Y-SIRT","volume":"27","author":"Mansouri","year":"2025","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.acra.2026.06.015_bib51","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4103\/njcp.njcp_305_25","article-title":"Machine Learning using MR \u0130maging Radiomics can Predict the Response of Large Hepatocellular Carcinoma to Transarterial Radioembolization","volume":"28","author":"Sarioglu","year":"2025","journal-title":"Niger J Clin Pract"},{"key":"10.1016\/j.acra.2026.06.015_bib52","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/MNM.0000000000001572","article-title":"The role of volumetric and textural analysis of pretreatment 18F-fluorodeoxyglucose PET\/computerized tomography images in predicting complete response to transarterial radioembolization in hepatocellular cancer","volume":"43","author":"Karahan \u015een","year":"2022","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.acra.2026.06.015_bib53","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.jvir.2023.06.023","article-title":"Early prediction of response of hepatocellular carcinoma to yttrium-90 radiation segmentectomy using a machine learning MR imaging radiomic approach","volume":"34","author":"Marinelli","year":"2023","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.acra.2026.06.015_bib54","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.diii.2022.01.009","article-title":"Comparison of MRI-based response criteria and radiomics for the prediction of early response to transarterial radioembolization in patients with hepatocellular carcinoma","volume":"103","author":"Aujay","year":"2022","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.acra.2026.06.015_bib55","first-page":"156","article-title":"Assessment of Y-90 radioembolization treatment response for hepatocellular carcinoma cases using MRI radiomics","volume":"33","author":"Mahmoud","year":"2024","journal-title":"Mol Imaging Radionucl Ther"},{"key":"10.1016\/j.acra.2026.06.015_bib56","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jacr.2023.12.029","article-title":"Radiomics features extracted from pre- and postprocedural imaging in early prediction of treatment response in patients undergoing transarterial radioembolization of hepatic lesions: a systematic review, meta-analysis, and quality appraisal study","volume":"21","author":"Mirza-Aghazadeh-Attari","year":"2024","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.acra.2026.06.015_bib57","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1007\/s10278-022-00762-0","article-title":"Using deep learning to predict treatment response in patients with hepatocellular carcinoma treated with Y90 radiation segmentectomy","volume":"36","author":"Wagstaff","year":"2023","journal-title":"J Digit Imaging"},{"key":"10.1016\/j.acra.2026.06.015_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1433480","article-title":"Arterial hypoperfusion as a negative predictive marker for primary hepatic malignancies treated with Y-90 glass microsphere transarterial radioembolization","volume":"14","author":"Kalaghchi","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.acra.2026.06.015_bib59","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1007\/s00330-022-08585-x","article-title":"Yttrium-90 radioembolization for unresectable hepatocellular carcinoma: predictive modeling strategies to anticipate tumor response and improve patient selection","volume":"32","author":"L\u00fcdemann","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.acra.2026.06.015_bib60","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1007\/s00261-020-02870-3","article-title":"Improved survival following transarterial radioembolization of infiltrative-appearance hepatocellular carcinoma","volume":"46","author":"Nisiewicz","year":"2021","journal-title":"Abdom Radiol ((NY))"},{"key":"10.1016\/j.acra.2026.06.015_bib61","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jvir.2020.06.027","article-title":"Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion: validation of the milan prognostic score","volume":"31","author":"Bargellini","year":"2020","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.acra.2026.06.015_bib62","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1148\/radiol.2020191606","article-title":"SARAH trial group, relationship of tumor radiation-absorbed dose to survival and response in hepatocellular carcinoma treated with transarterial radioembolization with 90Y in the SARAH Study","volume":"296","author":"Hermann","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2026.06.015_bib63","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1159\/000529676","article-title":"Computed tomography-defined sarcopenia in outcomes of patients with unresectable hepatocellular carcinoma undergoing radioembolization: assessment with total abdominal, psoas, and paraspinal muscles","volume":"12","author":"Wu","year":"2023","journal-title":"Liver Cancer"},{"key":"10.1016\/j.acra.2026.06.015_bib64","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.3390\/cancers15215195","article-title":"Impact of low skeletal muscle mass on long-term outcomes in hepatocellular carcinoma treated with trans-arterial radioembolization: a retrospective multi-center study","volume":"15","author":"Nam","year":"2023","journal-title":"Cancers ((Basel))"},{"key":"10.1016\/j.acra.2026.06.015_bib65","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000165","article-title":"Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial","volume":"7","author":"Surov","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.acra.2026.06.015_bib66","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/cancers12020356","article-title":"Visceral adipose tissue radiodensity is linked to prognosis in hepatocellular carcinoma patients treated with selective internal radiation therapy","volume":"12","author":"Ebadi","year":"2020","journal-title":"Cancers ((Basel))"},{"key":"10.1016\/j.acra.2026.06.015_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.108889","article-title":"Yttrium-90 radioembolization for hepatocellular carcinoma: Outcome prediction with MRI derived fat-free muscle area","volume":"125","author":"Faron","year":"2020","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.acra.2026.06.015_bib68","doi-asserted-by":"crossref","first-page":"281","DOI":"10.21873\/cdp.10321","article-title":"The apparent diffusion coefficient of the paraspinal and psoas muscles are of prognostic relevance in patients with hepatocellular carcinoma undergoing transarterial radioembolization","volume":"4","author":"Ehrengut","year":"2024","journal-title":"Cancer Diagn Progn"},{"key":"10.1016\/j.acra.2026.06.015_bib69","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00270-021-02874-6","article-title":"MRI-derived sarcopenia associated with increased mortality following Yttrium-90 radioembolization of hepatocellular carcinoma","volume":"44","author":"Guichet","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.acra.2026.06.015_bib70","article-title":"Radiomics-based nomogram as predictive model for prognosis of hepatocellular carcinoma with portal vein tumor thrombosis receiving radiotherapy","volume":"12","author":"Huang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.acra.2026.06.015_bib71","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/jcsm.13315","article-title":"Prognostic role of radiomics-based body composition analysis for the 1-year survival for hepatocellular carcinoma patients","volume":"14","author":"Saalfeld","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.acra.2026.06.015_bib72","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1007\/s00259-024-06805-8","article-title":"The role of biomarkers and dosimetry parameters in overall and progression free survival prediction for patients treated with personalized 90Y glass microspheres SIRT: a preliminary machine learning study","volume":"51","author":"Mansouri","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226004290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226004290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:57:37Z","timestamp":1787227057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633226004290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":72,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1076633226004290"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2026.06.015","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in CT and MRI for Yttrium-90 Radioembolization of Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2026.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Association of Academic Radiology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}